Foley JE, Sreenan S. Efficacy and Safety Comparison Between the DPP-4 Inhibitor Vildagliptin
and the Sulfonylurea Gliclazide After Two Years of Monotherapy in Drug-naïve Patients
with Type 2 Diabetes. Horm Metab Res 2009; 41: 905–909
In the original article Figure 2 was incorrect. In the line graph, the baseline data
(at week 0) for HbA1c were missing. The corrected figure is provided below. This mistake does not affect
the remaining content of the article.
This article is an erratum to 905 in: Journal of HMR, Issue 12, 2009 .
